Financials
Income statement
| Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|
| Total reported revenue | 12.5B | 13.4B | 13.5B | 13.6B |
| Cost of revenue | 10.2B | 11.7B | 11.2B | 11.2B |
| Gross profit | 2.3B | 1.7B | 2.3B | 2.4B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | — | — | — | — |
| Operating income | 790M | 132M | 674M | 729M |
| Non operating interest income | ||||
| Income | 11M | 9M | 5M | 2M |
| Expense | 24M | 22M | 21M | 19M |
| Other income expense | — | — | — | — |
| Pretax income | 973M | 109M | 682M | 921M |
| Tax provision | 255M | 72M | 190M | 264M |
| Net income | 718M | 38M | 492M | 656M |
| Basic EPS | — | — | — | 27.9 |
| Diluted EPS | — | — | — | 27.9 |
| Basic average shares | — | — | — | 23.2M |
| Diluted average shares | — | — | — | 23.2M |
| EBITDA | 963M | 216M | 742M | 966M |
| Net income from continuing op. | — | — | — | — |
| Minority interests | -6M | -10M | -11M | -10M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |